Adenosine Regulation of Alveolar Fluid Homeostasis

腺苷对肺泡液稳态的调节

基本信息

  • 批准号:
    7162956
  • 负责人:
  • 金额:
    $ 37.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-01-01 至 2008-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Pulmonary edema is removed from the alveolar airspace by active Na+ transport by alveolar epithelial cells. It is intuitive that active transport increases epithelial cell energy consumption at times when cellular energy stores could be compromised. Data from a variety of experimental systems indicate that cells match energy consumption with energy supply by reducing active Na+ transport when energy stores are reduced. To date no such counter-regulatory mechanisms have been described in alveolar epithelial cells. Adenosine is produced from metabolism of AMP when intracellular ATP consumption and/or cAMP production are high. We speculate that increased levels of cAMP (from b-receptor signaling) and AMP/ADP (from Na,K-ATPase activity) in the setting of lung injury provide substrate for adenosine production in the alveolus. We recently noted that adenosine has concentration dependent, bidirectional effects on alveolar active Na+ transport in isolated rat lungs. Specifically, low concentrations of adenosine (=10-8M) increase alveolar active Na+ transport by ~100% via type 2a adenosine receptors (A2aR) whereas high concentrations (=10-6M) reduce it via type 1 adenosine receptors (A1R). We have also identified these receptors in distal rat and mouse lung tissue and isolated rat and mouse alveolar type 2 epithelial cells. These new observations are the first descriptions of a role for adenosine and its receptors in the alveolar epithelium and the first autocrine/paracrine mechanism that conditionally up- and down-regulates alveolar epithelial active Na+ transport. Based on this preliminary data, we hypothesize that: Alveolar epithelial adenosine receptors participate in the regulation of active Na+ transport in normal and injured lungs. The known inter-relationship of adenosine with cAMP production and ATP consumption and our preliminary data cause us to propose a new paradigm of regulation of alveolar active Na+ transport. Specifically, we believe that in normal lung alveolar adenosine concentrations in the extracellular space are low and serve as a positive modulator of alveolar active Na+ transport, probably via an A2aR dependent pathway. Conversely, during lung injury high ATP utilization and cAMP production lead to extracellular adenosine concentrations sufficient to inhibit adenylyl cyclase and reduce active transport via an A1R dependent pathway. This model suggests that adenosine and its receptors participate in a feedback loop that allows alveolar epithelial cells to fine tune cAMP sensitive active Na+ transport in response to changes in ATP utilization and/or cAMP production. To test our hypothesis we are proposing the following 3 scientific aims: Aim 1: Characterize adenosine receptors in the alveolar epithelium and determine if, and how, they regulate alveolar active Na+ transport in normal lungs. Aim 2: Determine the mechanism(s) by which adenosine receptors modulate alveolar active Na+ transport. Aim 3: Determine if alveolar epithelial adenosine receptor signaling is protective or maladaptive during acute lung injury. The focused studies we are proposing integrate pharmacologic manipulations, genetically engineered mice, and gene transfer with physiologic models to generate models of gain and loss of epithelial adenosine receptor function that will allow us to test our hypothesis and to determine if adenosine receptors serve protective or maladaptive roles in the alveolar epithelium.
描述(由申请人提供):通过肺泡上皮细胞的活性Na+转运从肺泡空体中除去肺水肿。直观的是,当细胞能量储存损害时,主动转运会增加上皮细胞能量消耗。 来自各种实验系统的数据表明,当减少能源存储时,通过减少活性Na+传输,细胞与能量消耗匹配。迄今为止,在肺泡上皮细胞中尚未描述这种反调节机制。当细胞内ATP消耗和/或cAMP生产高时,腺苷是由AMP代谢产生的。我们推测,在肺损伤的情况下,cAMP的水平增加(来自B受体信号传导)和AMP/ADP(来自Na,K-ATPase活性)为肺泡中的腺苷产生提供了底物。 我们最近指出,腺苷对分离的大鼠肺中肺泡活性Na+转运的浓度依赖性,双向影响。 具体而言,低浓度的腺苷(= 10-8M)通过2A型腺苷受体(A2AR)增加肺泡活性Na+转运〜100%,而高浓度(= 10-6M)通过1型腺苷受体(A1R)减少了高浓度(= 10-6m)。 我们还鉴定了远端大鼠和小鼠肺组织以及分离的大鼠和小鼠肺泡2上皮细胞中的这些受体。 这些新观察结果是腺苷及其受体在肺泡上皮中的作用的第一个描述,也是第一个有条件地上调和下调肺泡上皮活动Na+转运的自分泌/旁分泌机制。 基于此初步数据,我们假设:肺泡上皮腺苷受体参与正常和受伤的肺中主动Na+转运的调节。腺苷与cAMP生产和ATP消耗以及我们的初步数据的已知相互关系使我们提出了对肺泡活性Na+运输的新范式。具体而言,我们认为,在正常的肺肺泡腺苷中,细胞外空间中的浓度很低,并且可能是通过A2AR依赖途径的肺泡活性Na+转运的正调节剂。 相反,在肺损伤期间,高ATP利用率和cAMP生产导致细胞外腺苷浓度足以抑制腺苷酸环化酶并通过A1R依赖性途径减少主动转运。该模型表明,腺苷及其受体参与反馈环,该反馈环使牙槽上皮细胞可以对ATP利用率变化和/或cAMP生产的变化进行微调cAMP敏感的活性Na+转运。为了检验我们的假设,我们提出以下3个科学目的:目标1:表征肺泡上皮中的腺苷受体,并确定它们是否以及如何调节正常肺中的肺泡活性Na+转运。 AIM 2:确定腺苷受体调节肺泡活性Na+转运的机制。 AIM 3:确定肺泡上皮腺苷受体信号在急性肺损伤过程中是否具有保护性或适应不良。我们提出的集中研究综合研究了药理学操纵,基因工程的小鼠以及与生理模型的基因转移,以产生上皮腺苷受体受体功能的获得和丧失模型,从而使我们能够测试我们的假设并确定腺苷受体在肺泡上的保护性或对腺苷的受体作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Phillip H Factor其他文献

Phillip H Factor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Phillip H Factor', 18)}}的其他基金

Effect of Traffic-Related Pollutants on Airway Beta2-Adrenergic Receptors
交通相关污染物对气道 β2 肾上腺素能受体的影响
  • 批准号:
    8279276
  • 财政年份:
    2011
  • 资助金额:
    $ 37.88万
  • 项目类别:
Adenosine Regulation of Alveolar Fluid Homeostasis
腺苷对肺泡液稳态的调节
  • 批准号:
    6856655
  • 财政年份:
    2005
  • 资助金额:
    $ 37.88万
  • 项目类别:
Adenosine Regulation of Alveolar Fluid Homeostasis
腺苷对肺泡液稳态的调节
  • 批准号:
    6998411
  • 财政年份:
    2005
  • 资助金额:
    $ 37.88万
  • 项目类别:
Adenosine Regulation of Alveolar Fluid Homeostasis
腺苷对肺泡液稳态的调节
  • 批准号:
    7333233
  • 财政年份:
    2005
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of airway epithelial Beta2-adrenergic receptors
气道上皮β2-肾上腺素能受体的作用
  • 批准号:
    6686968
  • 财政年份:
    2003
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of airway epithelial Beta2-adrenergic receptors
气道上皮β2-肾上腺素能受体的作用
  • 批准号:
    7109283
  • 财政年份:
    2003
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of airway epithelial Beta2-adrenergic receptors
气道上皮β2-肾上腺素能受体的作用
  • 批准号:
    6802703
  • 财政年份:
    2003
  • 资助金额:
    $ 37.88万
  • 项目类别:
Role of airway epithelial Beta2-adrenergic receptors
气道上皮β2-肾上腺素能受体的作用
  • 批准号:
    6941678
  • 财政年份:
    2003
  • 资助金额:
    $ 37.88万
  • 项目类别:
Effect/alveolar beta2 adrenergic receptor overexpression
效应/肺泡β2肾上腺素受体过度表达
  • 批准号:
    6754524
  • 财政年份:
    2001
  • 资助金额:
    $ 37.88万
  • 项目类别:
Effect/alveolar beta2 adrenergic receptor overexpression
效应/肺泡β2肾上腺素受体过度表达
  • 批准号:
    6537926
  • 财政年份:
    2001
  • 资助金额:
    $ 37.88万
  • 项目类别:

相似国自然基金

大肠杆菌基因工程菌发酵生产琥珀酸过程中CO2转运与固定的协同代谢调控
  • 批准号:
    21176059
  • 批准年份:
    2011
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目

相似海外基金

A microphysiological system with a synthetic hemoglobin, Blood Substitute, for mechanistic assessment of drug-induced liver injury
具有合成血红蛋白(血液替代品)的微生理系统,用于药物性肝损伤的机械评估
  • 批准号:
    10385048
  • 财政年份:
    2022
  • 资助金额:
    $ 37.88万
  • 项目类别:
A microphysiological system with a synthetic hemoglobin, Blood Substitute, for mechanistic assessment of drug-induced liver injury
具有合成血红蛋白(血液替代品)的微生理系统,用于药物性肝损伤的机械评估
  • 批准号:
    10625293
  • 财政年份:
    2022
  • 资助金额:
    $ 37.88万
  • 项目类别:
Molecular mechanisms of excitatory postsynaptic diversity
兴奋性突触后多样性的分子机制
  • 批准号:
    10542808
  • 财政年份:
    2021
  • 资助金额:
    $ 37.88万
  • 项目类别:
Molecular Physiology of Mitochondrial Calcium Transporters
线粒体钙转运蛋白的分子生理学
  • 批准号:
    10676910
  • 财政年份:
    2021
  • 资助金额:
    $ 37.88万
  • 项目类别:
Molecular Physiology of Mitochondrial Calcium Transporters
线粒体钙转运蛋白的分子生理学
  • 批准号:
    10487518
  • 财政年份:
    2021
  • 资助金额:
    $ 37.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了